Exact Mass: 316.02263739999995

Exact Mass Matches: 316.02263739999995

Found 40 metabolites which its exact mass value is equals to given mass value 316.02263739999995, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pentaerythritol tetranitrate

2,2-Bis((nitrooxy)methyl)-1,3-propanediol dinitric acid ester

C5H8N4O12 (316.0138728)

C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DA - Organic nitrates C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

9-(6-Methylsulfanylpurin-9-yl)-3H-purine-6-thione

6-(methylsulfanyl)-3,6-dihydro-[9,9-bipurine]-6-thione

C11H8N8S2 (316.0313328)

3-O-Methylellagic acid

3-O-Methylellagic acid

C15H8O8 (316.0219168)

ZINC585660850

ZINC585660850

C12H14Cl2N4S (316.0316184)

Calcium salicylate

Calcium salicylate

C14H12CaO6+2 (316.0259762)

blumeaxanthene II

blumeaxanthene II

C16H9ClO5 (316.01384939999997)

ellagic acid 3-monomethyl ether

ellagic acid 3-monomethyl ether

C15H8O8 (316.0219168)

Chlormycorrhizin A|Chloromycorrhizin A

Chlormycorrhizin A|Chloromycorrhizin A

C14H14Cl2O4 (316.0269104)

Srilankenyne

Srilankenyne

C14H18BrClO (316.0229468)

Chloromycorrhizinol A

Chloromycorrhizinol A

C14H14Cl2O4 (316.0269104)

4-methoxy-3-indolylmethyl glucosinolate aglycone

4-methoxy-3-indolylmethyl glucosinolate aglycone

C11H12N2O5S2 (316.01876219999997)

3-Methyl ellagic acid

6,7,13-trihydroxy-14-methoxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C15H8O8 (316.0219168)

3-O-methylellagic acid is a natural product found in Metrosideros perforata, Metrosideros robusta, and other organisms with data available.

Chrysoine resorcinol

Chrysoine resorcinol

C12H9N2NaO5S (316.0129864)

(7-Bromo-9,9-dimethyl-9H-fluoren-2-yl)boronic acid

(7-Bromo-9,9-dimethyl-9H-fluoren-2-yl)boronic acid

C15H14BBrO2 (316.0270154)

3-AMINO-2-(4-CHLOROBENZOYL)-6-NITROBENZ&

3-AMINO-2-(4-CHLOROBENZOYL)-6-NITROBENZ&

C15H9ClN2O4 (316.0250824)

Potassium dibenzyl phosphate

Potassium dibenzyl phosphate

C14H14KO4P (316.02667540000004)

tert-butyl 4-bromo-3,5-dimethoxybenzoate

tert-butyl 4-bromo-3,5-dimethoxybenzoate

C13H17BrO4 (316.0310142)

4-BROMO-3,5-DIETHOXY-BENZOICACID ETHYL ESTER

4-BROMO-3,5-DIETHOXY-BENZOICACID ETHYL ESTER

C13H17BrO4 (316.0310142)

6,7-DICHLORO-3-STYRYLQUINOXALIN-2-OL

6,7-DICHLORO-3-STYRYLQUINOXALIN-2-OL

C16H10Cl2N2O (316.017015)

Ethyl 5-bromo-2,4-diethoxybenzoate

Ethyl 5-bromo-2,4-diethoxybenzoate

C13H17BrO4 (316.0310142)

barium(2+),2-ethoxyethanolate

barium(2+),2-ethoxyethanolate

C8H18BaO4 (316.0257388)

PENTAERYTHRITOL TETRANITRATE:LACTOSE 1:4

PENTAERYTHRITOL TETRANITRATE:LACTOSE 1:4

C(CH2ONO2)4 (316.0138728)

1-[(2-CHLORO-2-PHENYLETHYL)SULFONYL]-2,4-DIFLUOROBENZENE

1-[(2-CHLORO-2-PHENYLETHYL)SULFONYL]-2,4-DIFLUOROBENZENE

C14H11ClF2O2S (316.01363200000003)

5-Bromo-1-(4-methoxybenzyl)-1H-benzo[d]imidazole

5-Bromo-1-(4-methoxybenzyl)-1H-benzo[d]imidazole

C15H13BrN2O (316.0211188)

2-thienyl-n n-bis(2-thienylmethylene)me&

2-thienyl-n n-bis(2-thienylmethylene)me&

C15H12N2S3 (316.0162592)

benzyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate

benzyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate

C13H8ClF3N2O2 (316.02263739999995)

2,5-Norbornadiene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexafluoro-, dimethyl ester

2,5-Norbornadiene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexafluoro-, dimethyl ester

C11H6F6O4 (316.0170268)

Pentaerithrityl tetranitrate

Pentaerithrityl tetranitrate

C5H8N4O12 (316.0138728)

C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DA - Organic nitrates C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

[[2-(4-methoxy-1H-indol-3-yl)ethanethioyl]amino] hydrogen sulfate

[[2-(4-methoxy-1H-indol-3-yl)ethanethioyl]amino] hydrogen sulfate

C11H12N2O5S2 (316.01876219999997)

6-Carboxy-4-chloroflavonol

6-Carboxy-4-chloroflavonol

C16H9ClO5 (316.01384939999997)

4-Bromo-2-methyl-2-(phenylthio)butyric acid ethyl ester

4-Bromo-2-methyl-2-(phenylthio)butyric acid ethyl ester

C13H17BrO2S (316.0132562)

FTX-6746

FTX-6746

C16H7ClF2N2O (316.0214946)

FTX-6746 is an orally active PPARG inhibitor. FTX-6746 shows potent tumor inhibition in mouse xenograft models[1].

2-chloro-9-hydroxy-10-methoxyfuro[2,3-a]xanthen-8-one

2-chloro-9-hydroxy-10-methoxyfuro[2,3-a]xanthen-8-one

C16H9ClO5 (316.01384939999997)

3-(4-hydroxyphenyl)-7-(methyldisulfanyl)cyclohepta[b]furan-2-one

3-(4-hydroxyphenyl)-7-(methyldisulfanyl)cyclohepta[b]furan-2-one

C16H12O3S2 (316.0227842)

9-chloro-8-(1-chloroprop-1-en-1-yl)-6-hydroxy-4,4-dimethyl-5-oxatricyclo[4.4.0.0¹,³]dec-8-ene-7,10-dione

9-chloro-8-(1-chloroprop-1-en-1-yl)-6-hydroxy-4,4-dimethyl-5-oxatricyclo[4.4.0.0¹,³]dec-8-ene-7,10-dione

C14H14Cl2O4 (316.0269104)

(2r)-3-{[(1z)-2-hydroxy-1-(hydroxyimino)-2-phosphonoethyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(1z)-2-hydroxy-1-(hydroxyimino)-2-phosphonoethyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C7H13N2O8PS (316.01302280000004)

4,5,6,7-tetrahydroxy-9,10-dioxoanthracene-2-carboxylic acid

4,5,6,7-tetrahydroxy-9,10-dioxoanthracene-2-carboxylic acid

C15H8O8 (316.0219168)

5,7-dichloro-4,12,12-trimethyl-3,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,4,6,8-tetraene-8,11-diol

5,7-dichloro-4,12,12-trimethyl-3,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,4,6,8-tetraene-8,11-diol

C14H14Cl2O4 (316.0269104)

chloromycorrhizin a

chloromycorrhizin a

C14H14Cl2O4 (316.0269104)

6,7,13-trihydroxy-14-methoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

6,7,13-trihydroxy-14-methoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C15H8O8 (316.0219168)